Assertion: carotid endarterectomy | /r/HasProperty | beneficial
Facets:
value: highly
type: DEGREE
value: for patients
type: TRANSITIVE-OBJECT
value: in preventing future strokes
type: PURPOSE
value: in summary
type: DEGREE
value: for these individuals
type: TRANSITIVE-OBJECT
Source sentences:
text: Carotid endarterectomy is beneficial if the symptoms are non-disabling, no tandem stenoses, high-grade stenosis.
text: Recent randomized prospective clinical trials have clearly showed that carotid endarterectomy is a highly beneficial treatment modality compared with the best medical treatment for patients with hemispheric and retinal TIAs or nondisabling strokes and ipsilateral high-grade stenosis of the internal carotid artery.6164
text: For these individuals, carotid endarterectomy can be highly beneficial in preventing future strokes.
text: Carotid endarterectomy is highly beneficial for patients with recent hemispheric, transient ischemic attacks or non-disabling strokes and ipsilateral high-grade (70-99%) stenosis.
text: Study investigators concluded that carotid endarterectomy is highly beneficial to patients with recent hemispheric or retinal transient ischemia or nondisabling strokes and ipsilateral severe carotid stenosis.
text: The small numbers of patients made it impossible to determine whether carotid endarterectomy was beneficial for patients with lesser degrees of stenosis.
text: In summary, carotid endarterectomy is beneficial for symptomatic patients with recent nondisabling carotid artery ischemic events and ipsilateral 70% to 99% carotid artery stenosis (Grade A recommendation).
text: Carotid endarterectomy is beneficial with a statistically significant absolute reduction of 5.8 percent in the risk of the primary end point of stroke within 5 years and a relative risk reduction of 55 percent.
text: Carotid endarterectomy, performed in medical centers with documented combined perioperative morbidity and mortality for asymptomatic endarterectomy of less than 3 percent, and on carefully selected patients who continue to have aggressive modifiable risk factor management is beneficial for patients who meet eligibility criteria of asymptomatic carotid stenosis exceeding 60 percent diameter reduction confirmed by arteriography.